OSLO, Norway, April 29, 2025 /PRNewswire/ -- Navamedic ASA (OSE: NAVA) today announced it has signed a renewed distribution agreement with TopRidge Pharma Limited (TopRidge) for Imdur®, valid until ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
AstraZeneca has handed China Medical System (CMS) certain rights to its heart and blood pressure drugs Imdur and Plendil in deals worth some $500 million. AstraZeneca has handed China Medical System ...
AstraZeneca today disclosed licensing agreements for rights to two of its medicines that will generate a combined $500 million for the pharma giant. China Medical System Holdings (CMS) agreed to pay ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results